Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by jewel9mon Feb 01, 2016 9:04pm

185 Views

Post# 24514641

RE:Article - SBM the world leader in carbohydrate tech

Great acticle, many products in the pipeline that generate billions in revenue.

TFC-1067 is not only safe but also boasts 8 times the efficacy of DeoxyArbutin. Given the numerous benefits that TFC-1067 provides over its competitors, multinational cosmetic conglomerates like Proctor and Gamble, Allergan, L’Oreal, and Amore Pacific Corporation with marketed skin lighteners are interested in Sirona’s leading edge compound.
Thses are some great names to be mentioned with.

This article clearly explains the potenial of SBM.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec